UrgoClean®
Sterile non-woven pad, composed of poly-absorbent fibres that are highly absorbent and cohesive.
FEATURES
FEATURES | BENEFITS |
---|---|
|
|
|
|
|
|
INDICATIONS
- Deslouching phase of chronic exuding wounds (eg leg ulcers, pressure injuries, diabetic foot ulcers)
- Potentially sloughy wounds
- acute wounds (burns, skin abrasions, traumatic wounds)
- post-operative wound
- cancerous wounds
CONTRAINDICATIONS
- Do not use if there is a known sensitivity to UrgoClean®
- Do not use UrgoClean® as a surgical sponge for heavily bleeding wounds
PRECAUTIONS
- The soft-adherent TLC layer of UrgoClean® adheres to latex gloves. It is therefore recommended that the dressing be handled carefully, avoiding any contact with the soft-adherent side or using sterile forceps
- The concomitant use of a cream, lotion, ointment or emulsion is not recommended
- Due to the non-occlusive nature of this dressing, UrgoClean® can be used on infected wounds under close medical supervision
- During the desloughing process, the wound may appear to be larger in size. This is due to the effective removal of slough
- UrgoClean® must not be used in a hyperbaric chamber
- Do not re-sterilise the dressing
- Check that the sterile protector is intact before use. Do not use if package is damaged
- Single use sterile individual packaging: re-using a single use dressing may lead to risks of infection
DIRECTIONS FOR USE
PRODUCT OPTIONS
Product Code | Product Size | Units/Box |
---|---|---|
100369 | 6x6cm | 10 |
100370 | 10x10cm | 10 |
100372 | 15x20cm | 10 |
Supplied in boxes of 10 individually packed sterile dressings
CLINICAL EVIDENCE
- Grothier L. Improving clinical outcomes and patient experience through the use of desloughing. Br J Comm Nurs 2015;20(9):1-6.
- Meaume S et al. The importance of pain reduction through dressing selection in routine wound management the MAPP study. J Wound Care
2004;13(10): 409-13.
Page updated on 20 May 2024